Nicole McMullen, PharmD, BCOP

Articles by Nicole McMullen, PharmD, BCOP

Image Credit: David A. Litman | stock.adobe.com

Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer

ByNicole McMullen, PharmD, BCOP,Cassandra Perkey, PharmD, BCOP,Manale Maksour, PharmD, BCPS,Bradley Winegar, PharmD,Cherise Steib, PharmD,Robert Carr, PharmD, BCOP,Melody Chang, MBA, RPh, BCOP

October 15th 2025

AI in health care -- Image credit: Toowongsa | stock.adobe.com

Revolutionizing Outpatient Oncology Care: The Seamless Integration of Artificial Intelligence

ByManale Maksour, PharmD, BCPS,Cassandra Perkey, PharmD, BCOP,Brooke Peters, PharmD, BCOP,Bradley Winegar, PharmD,Nicole McMullen, PharmD, BCOP,Melody Chang, MBA, RPh, BCOP

October 16th 2024

Artificial intelligence holds immense potential to address the rising demand for oncology services and improve patient outcomes by facilitating more effective, efficient, personalized cancer care.

Latest Updated Articles

Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
Published: October 15th 2025 | Updated:

Nicole McMullen, PharmD, BCOP

Articles by Nicole McMullen, PharmD, BCOP

Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer

Revolutionizing Outpatient Oncology Care: The Seamless Integration of Artificial Intelligence

Latest Updated Articles

Trending on Pharmacy Times

COVID-19 mRNA Vaccines May Boost Immunotherapy Response in Cancer

States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments

FDA Approves Single-Injection Maintenance Regimen of Mirikizumab-Mrkz for Ulcertive Colitis

Court Ruling Highlights Risks of Improper Dose Adjustments

FDA Expands Approval of Sotatercept-csrk for Pulmonary Arterial Hypertension